Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 184
Filter
1.
Nurse Educ Pract ; 51: 102987, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33610023

ABSTRACT

The purpose was to capture the experiences of cultural, personal and professional development during International Clinical Placement (ICP) among nursing students from three European countries. The paper presents findings based on the analysis of 23 reflections written by students immediately after returning from their ICP. The design builds on a qualitative study using a phenomenological approach and meaning condensation inspired by Kirsti Malterud. The analysis revealed four themes: Communication and barriers to be overcome, Culture as a serious business, Personal and professional achievements and Challenges and the importance of preceptorship. The ICP impacted on the participants' personal as well as professional way of understanding themselves as students and future nurses. A profound difference was seen between the achieved learning outcomes of participants completing an ICP in a high- or low-income country, respectively. Language barriers, the local culture and different nursing cultures were often challenging and pushed participants out of their comfort zone. All participants developed their cultural understanding in accordance with the Papadopoulos, Tilki and Taylor Model for Developing Cultural Competence. Findings indicate that educational institutions should establish well-planned exchange opportunities that adopt a two-way reciprocal (Erasmus) exchange programmes and be aware of the value of an appointed preceptor in the host country.


Subject(s)
Education, Nursing, Baccalaureate , International Educational Exchange , Students, Nursing , Cultural Competency , Europe , Humans , Qualitative Research
2.
Science ; 365(6451): 325-327, 2019 07 26.
Article in English | MEDLINE | ID: mdl-31346056
3.
Annu Rev Food Sci Technol ; 10: 21-41, 2019 03 25.
Article in English | MEDLINE | ID: mdl-30633565

ABSTRACT

Periodically someone comes into a field and forces a change in direction, a paradigm shift. Owen Fennema was such a person in food science and technology. When he started his academic career, curricula in food science and technology had courses describing how to process plant produce and animal tissue into safer food with an extended shelf life. The "why" was often overlooked. Owen changed all that. He participated in and greatly contributed to a paradigm shift in teaching food science by editing one of the most important textbook series in food science and technology. In addition, his research on water and ice as they impacted the chemical, physical, and biological characteristics of plant and animal tissues extended the bounds of knowledge. He did the same for edible bilayers with research done in his laboratory. Who was this man, and how could he have such impact? Hopefully, this review provides some insights into Owen Fennema, Renaissance man.


Subject(s)
Food Technology/history , Food Safety , History, 20th Century
4.
Osteoporos Int ; 27(11): 3165-3175, 2016 11.
Article in English | MEDLINE | ID: mdl-27230521

ABSTRACT

PURPOSE: The purpose of this study was to investigate if a 2-year intervention with a minimal resource fracture liaison service (FLS) was associated with increased investigation and medical treatment and if treatment was related to reduced re-fracture risk. METHODS: The FLS started in 2013 using existing secretaries (without an FLS coordinator) at the emergency department and orthopaedic wards to identify risk patients. All patients older than 50 years of age with a fractured hip, vertebra, shoulder, wrist or pelvis were followed during 2013-2014 (n = 2713) and compared with their historic counterparts in 2011-2012 (n = 2616) at the same hospital. Re-fractures were X-ray verified. A time-dependent adjusted (for age, sex, previous fracture, index fracture type, prevalent treatment, comorbidity and secondary osteoporosis) Cox model was used. RESULTS: The minimal resource FLS increased the proportion of DXA-investigated patients after fracture from 7.6 to 39.6 % (p < 0.001) and the treatment rate after fracture from 12.6 to 31.8 %, which is well in line with FLS types using the conventional coordinator model. Treated patients had a 51 % lower risk of any re-fracture than untreated patients (HR 0.49, 95 % CI 0.37-0.65 p < 0.001). CONCLUSIONS: We found that our minimal resource FLS was effective in increasing investigation and treatment, in line with conventional coordinator-based services, and that treated patients had a 51 % reduced risk of new fractures, indicating that also non-coordinator based fracture liaison services can improve secondary prevention of fractures.


Subject(s)
Health Resources , Osteoporotic Fractures/prevention & control , Osteoporotic Fractures/therapy , Secondary Prevention , Aged , Aged, 80 and over , Bone Density , Bone Density Conservation Agents/therapeutic use , Female , Humans , Male , Mortality , Osteoporosis
5.
Science ; 351(6272): 478-82, 2016 Jan 29.
Article in English | MEDLINE | ID: mdl-26823422

ABSTRACT

Mid-ocean ridge magmatism is driven by seafloor spreading and decompression melting of the upper mantle. Melt production is apparently modulated by glacial-interglacial changes in sea level, raising the possibility that magmatic flux acts as a negative feedback on ice-sheet size. The timing of melt variability is poorly constrained, however, precluding a clear link between ridge magmatism and Pleistocene climate transitions. Here we present well-dated sedimentary records from the East Pacific Rise that show evidence of enhanced hydrothermal activity during the last two glacial terminations. We suggest that glacial maxima and lowering of sea level caused anomalous melting in the upper mantle and that the subsequent magmatic anomalies promoted deglaciation through the release of mantle heat and carbon at mid-ocean ridges.

6.
Equine Vet J Suppl ; (45): 26-30, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24304400

ABSTRACT

REASONS FOR PERFORMING STUDY: In order for changes in lameness to be accurately and repeatably detected and recorded during diagnostic investigations, an objective measure of lameness is required. OBJECTIVES: To ascertain whether an inertial sensor-based system can distinguish between a positive and negative response to diagnostic anaesthesia of the foot and objectively assess the effect of a positive response on the trot. STUDY DESIGN: Restrospective clinical study. METHODS: Data obtained during lameness investigations undertaken between August 2011 and December 2012 in which either a palmar digital or abaxial sesamoid nerve block was performed were retrospectively reviewed. Response to diagnostic anaesthesia was categorised as positive (n = 14) or negative (n = 9) by one of 2 evaluators before analysis of kinematic data (i.e. blinded). Changes in maximum and minimum head difference (ΔHDMax and ΔHDMin) and change in head movement asymmetry/change in pelvic movement asymmetry (ΔHMA/PMA, measure of asymmetry) allocated to each limb were calculated. A Kruskal-Wallis one way analysis of variance on ranks was performed. Receiver operating characteristic (ROC) curves were generated for ΔHDMax, ΔHDMin and ΔHMA for the blocked limb to identify cut-off values to distinguish positive and negative responses to the block. RESULTS: Median ΔHDMax and ΔHDMin were significantly greater after a positive response to diagnostic anaesthesia (P<0.01). Change in head movement asymmetry allocated to the blocked limb and contralateral forelimb and ΔPMA allocated to the contralateral hindlimb were significantly greater in the positive response group (P<0.05). Change in head movement asymmetry allocated to the blocked limb and ΔHDMax and ΔHDMin are useful diagnostic tests for identifying positive response to anaesthesia (area under the curve = 0.98, 0.83 and 0.96 respectively). CONCLUSIONS: An inertial sensor-based system can identify a positive response to diagnostic anaesthesia of the foot. Symmetry of movement allocated to the blocked limb, contralateral forelimb and contralateral hindlimb significantly improve, and head movement significantly decreases in horses with a positive response to the block. Cut-off values for a positive response have been identified with good sensitivity and specificity. Forelimb lameness significantly affects contralateral hindlimb movement, which has implications for the investigation of multi-limb lameness.


Subject(s)
Horse Diseases , Lameness, Animal , Anesthesia , Animals , Biomechanical Phenomena , Forelimb , Hindlimb , Horse Diseases/diagnosis , Horses , Lameness, Animal/diagnosis
7.
Equine Vet J Suppl ; (43): 8-11, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23447870

ABSTRACT

OBJECTIVES: A wireless, inertial sensor-based system has previously been validated for evaluation of equine lameness. However, threshold values have not been determined for the assessment of responses to flexion tests. The aim of this investigation was to evaluate a sensor-based system for objective assessment of the response to flexion. METHODS: Healthy adult horses (n = 17) in work were recruited prospectively. Horses were instrumented with sensors on the head (accelerometer), pelvis (accelerometer) and right forelimb (gyroscope), before trotting in a straight line (minimum 25 strides) for 2 consecutive trials. Sensors measured 1) vertical pelvic movement asymmetry (PMA) for both right and left hindlimb strides and 2) average difference in maximum and minimum pelvic height (PDMax and PDMin) between right and left hindlimb strides in millimetres. A hindlimb was randomly selected for proximal flexion (60 s), after which the horse trotted a minimum of 10 strides. Response to flexion was blindly assessed as negative or positive by an experienced observer. Changes in PMA, PDMax and PDMin between baseline and flexion examinations were calculated for each test. Statistical analysis consisted of a Pearson's product moment test and linear regression on baseline trials, Mann-Whitney rank sum test for effect of flexion and receiver operator curve (ROC) analysis of test parameters. RESULTS: There was a strong correlation between trials for PMA, PDMin and PDMax measurements (P < 0.001). A positive flexion test resulted in a significant increase in PMA (P = 0.021) and PDMax (P = 0.05) only. Receiver-operator curve analysis established cut-off values for change in PMA and PDMax of 0.068 and 4.47 mm, respectively (sensitivity = 0.71, specificity = 0.65) to indicate a positive response to flexion. CONCLUSIONS: A positive response to flexion resulted in significant changes to objective measurements of pelvic symmetry. POTENTIAL RELEVANCE: Findings support the use of inertial sensor systems to objectively assess response to flexion tests. Further investigation is warranted to establish cut-off values for objective assessment of other diagnostic procedures.


Subject(s)
Horse Diseases/diagnosis , Lameness, Animal/diagnosis , Monitoring, Ambulatory/veterinary , Wireless Technology/instrumentation , Animals , Female , Forelimb , Gait , Head/physiology , Horses , Male , Monitoring, Ambulatory/instrumentation , Motor Activity , Pelvis/physiology
8.
Neuroscience ; 171(4): 1041-53, 2010 Dec 29.
Article in English | MEDLINE | ID: mdl-20888396

ABSTRACT

The presynaptic, hemicholinium-3 sensitive, high-affinity choline transporter (CHT) supplies choline for acetylcholine (ACh) synthesis. In mice, a homozygous deletion of CHT (CHT-/-) leads to premature cessation of spontaneous or evoked neuromuscular signaling and is associated with perinatal cyanosis and lethality within 1 h. Heterozygous (CHT+/-) mice exhibit diminished brain ACh levels and demonstrate an inability to sustain vigorous motor activity. We sought to explore the contribution of CHT gene dosage to motor function in greater detail using transgenic mice where CHT is expressed under control of the motor neuron promoter Hb9 (Hb9:CHT). On a CHT-/- background, the Hb9:CHT transgene conferred mice with the ability to move and breath for a postnatal period of ∼24 h, thus increasing survival. Conversely, Hb9:CHT expression on a wild-type background (CHT+/+;Hb9:CHT) leads to an increased capacity for treadmill running compared to wild-type littermates. Analysis of the stimulated compound muscle action potential (CMAP) in these animals under basal conditions established that CHT+/+;Hb9:CHT mice display an unexpected, bidirectional change, producing either elevated or reduced CMAP amplitude, relative to CHT+/+ animals. To examine whether these two groups arise from underlying changes in synaptic properties, we used high-frequency stimulation of motor axons to assess CMAP recovery kinetics. Although CHT+/+; Hb9:CHT mice in the two groups display an equivalent, time-dependent reduction in CMAP amplitude, animals with a higher basal CMAP amplitude demonstrate a significantly enhanced rate of recovery. To explain our findings, we propose a model whereby CHT support for neuromuscular signaling involves contributions to ACh synthesis as well as cholinergic synaptic vesicle availability.


Subject(s)
Membrane Transport Proteins/metabolism , Motor Activity/physiology , Motor Neurons/cytology , Motor Neurons/metabolism , Synapses/metabolism , Acetylcholine/pharmacology , Acetylcholinesterase/metabolism , Action Potentials/genetics , Animals , Animals, Newborn , Behavior, Animal , Brain/cytology , Choline O-Acetyltransferase/metabolism , Electric Stimulation/methods , Exercise Test/methods , GPI-Linked Proteins/metabolism , Gene Expression Regulation, Developmental/genetics , Green Fluorescent Proteins/genetics , Homeodomain Proteins/genetics , Membrane Transport Proteins/genetics , Mice , Mice, Transgenic , Motor Activity/genetics , Muscle, Skeletal/physiology , Nerve Tissue Proteins , Neuromuscular Junction/metabolism , Statistics, Nonparametric , Transcription Factors/genetics
9.
Diabetes Obes Metab ; 10(1): 64-74, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17970755

ABSTRACT

AIM: We had previously demonstrated that vascular and neural dysfunction in Zucker diabetic fatty (ZDF) rats is progressive. In this study, we sought to determine whether monotherapy of ZDF rats can reverse the vascular and nerve defects. METHODS: ZDF rats at 16 weeks of age were treated for 12 weeks with the angiotensin-converting enzyme inhibitor enalapril, the antioxidant alpha-lipoic acid, the HMG-CoA reductase inhibitor rosuvastatin or the PPARgamma agonist rosiglitazone. Vasodilation of epineurial arterioles was measured by videomicroscopy. Endoneurial blood flow (EBF) was measured by hydrogen clearance, and nerve conduction velocity was measured following electrical stimulation of motor or sensory nerves. RESULTS: Motor nerve conduction velocity (MNCV), sensory nerve conduction velocity (SNCV) (70 and 77% of control, respectively), EBF (64% of control), and vascular relaxation in response to acetylcholine (50% of control) and calcitonin gene-related peptide (CGRP; 73% of control) are impaired in ZDF rats at 28 weeks of age compared with lean littermate controls. Treatment with enalapril and alpha-lipoic acid attenuated the decrease in MNCV and SNCV. Enalapril, alpha-lipoic acid and rosiglitazone treatment of ZDF rats were partially effective in improving endothelium-dependent vascular dysfunction as measured by vascular relaxation in response to acetylcholine. The same drugs also attenuated the decrease in EBF. However, impairment in vascular relaxation in response to CGRP was improved with only alpha-lipoic acid or rosuvastatin treatment. The increase in superoxide and nitrotyrosine levels in vascular tissue was attenuated by all treatments. CONCLUSIONS: The efficacy of monotherapy treatment of ZDF rats using different classes of drugs for vascular and neural dysfunction once complications have developed did not achieve expected levels. This could be because of the complex aetiology of vascular and neural disease in type 2 diabetes.


Subject(s)
Diabetes Mellitus, Type 2/etiology , Diabetic Angiopathies/etiology , Diabetic Neuropathies/etiology , Neural Conduction , Obesity/physiopathology , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/metabolism , Diabetic Angiopathies/drug therapy , Diabetic Angiopathies/metabolism , Diabetic Neuropathies/drug therapy , Diabetic Neuropathies/metabolism , Male , Motor Neurons/physiology , Rats , Rats, Zucker , Treatment Outcome
10.
Phys Med Biol ; 50(14): 3211-9, 2005 Jul 21.
Article in English | MEDLINE | ID: mdl-16177504

ABSTRACT

Samples of cortical bone, derived from human femur, have been studied using terahertz time-domain transmission spectroscopy. The relationship between the broadband THz parameters and the previously acquired values of Young's modulus and x-ray attenuation (CT number), and the density of each bone sample, is investigated. The only significant correlation is that between THz transmission and sample density, suggesting that the potential use of THz radiation as a non-invasive probe of bone quality is limited. The spectra of absorption coefficient and refractive index are plotted over the frequency range 0.1-1.25 THz. There is evidence that the sample hydration state is a factor in the resultant THz parameters.


Subject(s)
Femur/diagnostic imaging , Bone Density , Electromagnetic Phenomena , Humans , Spectrum Analysis/instrumentation , Spectrum Analysis/methods , Tomography, X-Ray Computed
11.
Arterioscler Thromb Vasc Biol ; 25(8): 1617-22, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15933248

ABSTRACT

OBJECTIVE: Inducible nitric oxide synthase (iNOS) is expressed in arteries during inflammation and may contribute to vascular dysfunction. Effects of gene transfer of iNOS to carotid arteries were examined in vitro in the absence of systemic inflammation to allow examination of mechanisms by which iNOS impairs contraction and relaxation. METHODS AND RESULTS: After gene transfer of iNOS with an adenovirus (AdiNOS), constrictor responses to phenylephrine (PE) and U46619 were impaired. After AdiNOS, inhibition of soluble guanylate cyclase (sGC) with 1H-[1,2,4]oxadiazolo-[4,3,2]quinoxalin-1-one (ODQ) reduced the EC50 for PE from 4.33+/-0.78 micromol/L to 1.15+/-0.43 micromol/L (mean+/-SEM). These results imply that iNOS impairs contraction by activation of the NO/cGMP pathway. Relaxation to acetylcholine (ACh) also was impaired after AdiNOS. Sepiapterin (300 micromol/L), the precursor for tetrahydrobiopterin (BH4), improved relaxation to Ach. Because BH4 is an essential cofactor for production of NO by both iNOS and endothelial nitric oxide synthase (eNOS), these results suggest that iNOS may reduce production of NO by eNOS by limiting availability of BH4. Next, we examined effects of expression of iNOS in endothelium and adventitia. Selective expression of iNOS in endothelium, but not adventitia, impaired contraction to phenylephrine and relaxation to acetylcholine. CONCLUSIONS: We conclude that: (1) iNOS may impair contraction in part by activation of sGC; (2) iNOS impairs relaxation, at least in part, by limiting availability of BH4; and (3) expression of iNOS in endothelium may be a more important mediator of vascular dysfunction than expression of iNOS in adventitia.


Subject(s)
Carotid Artery Diseases/physiopathology , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Vasculitis/physiopathology , Adenoviridae/genetics , Animals , Carotid Arteries/physiology , Carotid Artery Diseases/metabolism , Endothelium, Vascular/physiology , Gene Expression Regulation, Enzymologic , Gene Transfer Techniques , Male , Rabbits , Vasculitis/metabolism , Vasoconstriction/physiology , Vasodilation/physiology
12.
Exp Diabesity Res ; 5(2): 123-35, 2004.
Article in English | MEDLINE | ID: mdl-15203883

ABSTRACT

In the present study, the authors examined whether treating streptozotocin-induced diabetic rats with the combination of alpha-lipoic acid and fidarestat, an aldose reductase inhibitor, can promote the formation of dihydrolipoic acid in diabetic animals and thereby enhance the efficacy of alpha-lipoic acid as monotherapy toward preventing diabetic vascular and neural dysfunction. Treating diabetic rats with the combination of 0.25% alpha-lipoic acid (in the diet) and fidarestat (3 mg/kg body weight) prevented the diabetes-induced slowing of motor nerve conduction velocity and endoneurial blood flow. This therapy also significantly improved acetylcholine-mediated vasodilation in epineurial arterioles of the sciatic nerve compared to nontreated diabetic rats. Treating diabetic rats with 0.25% alpha-lipoic acid and fidarestat (3 mg/kg body weight) was equally or more effective in preventing vascular and neural dysfunction than was monotherapy of diabetic rats with higher doses of alpha-lipoic acid or fidarestat. Treating diabetic rats with the combination of 0.25% alpha-lipoic acid and fidarestat (3 mg/kg body weight) significantly improved several markers of oxidative stress and increased the serum levels of both alpha-lipoic acid and dihydrolipoic acid. These studies suggest that combination therapy consisting of alpha-lipoic acid and fidarestat may be more efficacious in preventing diabetes-induced vascular and neural dysfunction in peripheral tissue compared to monotherapy, which requires higher doses to be equally effective. The effect of this combination therapy may in part be due to the increased production and/or level of dihydrolipoic acid.


Subject(s)
Blood Flow Velocity/drug effects , Blood Glucose/metabolism , Imidazolidines/pharmacology , Neural Conduction/drug effects , Thioctic Acid/pharmacology , Acetylcholine/pharmacology , Animals , Arterioles/drug effects , Arterioles/physiology , Arterioles/physiopathology , Blood Glucose/drug effects , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/metabolism , Fructose/metabolism , Glutathione/metabolism , Inositol/metabolism , Lens, Crystalline/drug effects , Lens, Crystalline/metabolism , Male , Motor Neurons/drug effects , Motor Neurons/physiology , Rats , Rats, Sprague-Dawley , Sciatic Nerve/blood supply , Sorbitol/metabolism , Superoxides/blood
13.
Pediatr Surg Int ; 20(3): 211-4, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15083327

ABSTRACT

Several studies in animal models demonstrate that peel formation in gastroschisis is due to the accumulation and activation of intestinal waste products (IWP) in the amniotic fluid. We reviewed our recent experience with gastroschisis and asked the following questions: First, does staining of the bowel and amniotic fluid with IWP correlate with intestinal peel formation? Second, what prenatal ultrasound findings indicate that peel formation is occurring in utero? Over two years, 16 neonates were treated for gastroschisis; twelve had been diagnosed by prenatal ultrasound and followed closely. Patients were grouped based on the presence of IWP in the amniotic fluid at the time of delivery (staining or no staining), and outcomes were reviewed. All neonates in the staining group (n=7) had a fibrinous peel present at the time of birth whereas a peel was absent in all neonates in the no-staining group (n=9). Matting of the bowel was seen by prenatal ultrasound in four patients in the staining group (0/8 in the no-staining group) and correlated with peel formation (Fisher's exact test p =0.007). Primary closure was done in 14 of the infants, and two required silo closure. In neonates with gastroschisis, staining of the amniotic fluid and bowel serosa with IWP correlated with intestinal peel formation. The ultrasound findings of matting correlated with both peel formation and staining with IWP. These results suggest that spillage of IWP into the amniotic fluid is one of the factors in peel formation in gastroschisis. Identification of matting of the bowel by prenatal ultrasound indicates formation of a peel.


Subject(s)
Amniotic Fluid , Gastroschisis/diagnostic imaging , Gastroschisis/pathology , Meconium , Ultrasonography, Prenatal , Female , Gastroschisis/epidemiology , Humans , Infant, Newborn , Pregnancy , United States/epidemiology
14.
Stroke ; 33(9): 2292-6, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12215601

ABSTRACT

BACKGROUND AND PURPOSE: These studies evaluated whether gene transfer of inducible nitric oxide synthase (iNOS) is a sufficient stimulus to produce vascular dysfunction in cerebral arteries. METHODS: Intracranial (pial) arteries were dissected from human brain tissue obtained during elective surgery. Isolated human arteries were incubated in vitro with adenovirus containing iNOS (AdiNOS) or a nonexpressive transgene (control, AdBglII) (500 micro L, 3x10(9) plaque-forming units per milliliter), and vascular function was examined 24 hours later. In anesthetized rabbits, AdiNOS or AdBglII (300 microL 1x10(10)) was injected into the cisterna magna. Three days later, the basilar artery was removed, and reactivity was examined ex vivo. RESULTS: In submaximally precontracted vessels, we observed impairment of NO-dependent relaxation in human cerebral arteries after gene transfer of iNOS. Maximum relaxation to bradykinin (1 micromol/L, an endothelium-dependent agonist) was 77+/-11% (mean+/-SE) after AdBglII and 31+/-22% (P<0.05) after AdiNOS. After AdiNOS, responses to nitroprusside (an endothelium-independent NO donor) also were impaired. Responses to both nitroprusside and bradykinin were improved by aminoguanidine (300 micromol/L), an inhibitor of iNOS. AdiNOS produced no change in vasoconstrictor responses to U46619. In basilar arteries from rabbits examined in vitro after gene transfer in vivo, responses to histamine, serotonin, and nitroprusside all were similar after AdiNOS or AdBglII. In contrast, relaxation to acetylcholine was significantly depressed after AdiNOS. Maximum relaxation to acetylcholine (10 micromol/L) was 90+/-3% after AdBglII and 68+/-5% (P<0.05) after AdiNOS. Relaxation of arteries after AdiNOS was improved by aminoguanidine. CONCLUSIONS: These studies suggest that expression of iNOS may impair NO-dependent relaxation in both human and rabbit cerebral arteries.


Subject(s)
Cerebral Arteries/drug effects , Nitric Oxide Synthase/genetics , Vasodilation/drug effects , Vasomotor System/drug effects , Animals , Bradykinin/pharmacology , Cerebral Arteries/cytology , Cerebral Arteries/physiology , Gene Transfer Techniques , Humans , Immunohistochemistry , In Vitro Techniques , Male , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase/pharmacology , Nitric Oxide Synthase Type II , Rabbits , Vasoconstriction/drug effects , Vasoconstriction/physiology , Vasoconstrictor Agents/pharmacology , Vasodilation/physiology , Vasodilator Agents/pharmacology , Vasomotor System/physiology
15.
Arterioscler Thromb Vasc Biol ; 21(8): 1281-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11498454

ABSTRACT

Proinflammatory stimuli produce expression of inducible NO-synthase (iNOS) within blood vessels and are associated with impaired endothelium-dependent relaxation. Gene transfer of iNOS was used to test the hypothesis that expression of iNOS in blood vessels produces impairment of NO-dependent relaxation as well as contraction. An adenoviral vector containing cDNA for murine iNOS, AdCMViNOS, and a control virus, AdCMVBglII, were used for gene transfer to rabbit carotid arteries in vitro and in vivo. After gene transfer of iNOS in vitro, contractile responses to KCl, phenylephrine, and U46619 were impaired. Relaxation in response to acetylcholine, ADP, A23187, and nitroprusside was also impaired. For example, maximum relaxation of vessels to acetylcholine (10 micromol/L) was 78+/-4% (mean+/-SE) after AdBglII (10(10.5) plaque-forming units) and 34+/-5% after AdiNOS (10(10.5) plaque-forming units, P<0.05). NO-independent relaxation in response to 8-bromo-cGMP and papaverine was not impaired after AdiNOS. Contraction and relaxation were improved in carotid arteries expressing iNOS by aminoguanidine and L-N-iminoethyl lysine, inhibitors of iNOS. After intraluminal gene transfer of iNOS in vivo, contraction of vessels in vitro was normal, but responses to acetylcholine were impaired. In summary, the major finding is that NO-dependent relaxation is impaired in arteries after gene transfer of iNOS in vitro and in vivo. Thus, expression of iNOS per se impairs NO-dependent relaxation.


Subject(s)
Carotid Arteries/physiology , Gene Transfer Techniques , Nitric Oxide Synthase/genetics , Nitric Oxide/metabolism , Vasodilation/physiology , Adenoviridae , Animals , Carotid Arteries/enzymology , Carotid Arteries/pathology , DNA, Complementary , Genetic Vectors , Immunohistochemistry , In Vitro Techniques , Male , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Rabbits , Superoxides , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
16.
Br J Pharmacol ; 134(1): 21-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11522593

ABSTRACT

1. To further explore the effect of antioxidants in preventing diabetes-induced vascular and neural dysfunction we treated streptozotocin-induced diabetic rats daily with subcutaneous injections of 10 mg kg(-1) of M40403 (n=11) and compared the results obtained from 17 control rats and 14 untreated diabetic rats. M40403 is a manganese(II) complex with a bis(cyclo-hexylpyridine)-substituted macrocyclic ligand that was designed to be a selective functional mimetic of superoxide dismutase. Thus, M40403 provides a useful tool to evaluate the roles of superoxide in disease states. 2. Treatment with M40403 significantly improved diabetes-induced decrease in endoneurial blood flow, acetylcholine-mediated vascular relaxation in arterioles that provide circulation to the region of the sciatic nerve, and motor nerve conduction velocity (P<0.05). M40403 treatment also reduced the appearance of superoxide in the aorta and epineurial vessels and peroxynitrite in epineurial vessels. Treating diabetic rats with M40403 reduced the diabetes-induced increase in thiobarbituric acid reactive substances in serum but did not prevent the decrease in lens glutathione level. Treating diabetic rats with M40403 did not improve sciatic nerve Na(+)/K(+) ATPase activity or the sorbitol, fructose or myo-inositol content of the sciatic nerve. 3. These studies provide additional evidence that diabetes-induced oxidative stress and the generation of superoxide and perhaps peroxynitrite may be partially responsible for the development of diabetic vascular and neural complications.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Neural Conduction/drug effects , Organometallic Compounds/pharmacology , Sciatic Nerve/drug effects , Tyrosine/analogs & derivatives , Acetylcholine/pharmacology , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Blood Vessels/drug effects , Blood Vessels/metabolism , Blood Vessels/physiopathology , Body Weight/drug effects , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Dose-Response Relationship, Drug , Fatty Acids, Nonesterified/blood , Fructose/metabolism , Inositol/metabolism , Male , Manganese , Rats , Rats, Sprague-Dawley , Regional Blood Flow/drug effects , Sciatic Nerve/blood supply , Sciatic Nerve/physiopathology , Sodium-Potassium-Exchanging ATPase/drug effects , Sodium-Potassium-Exchanging ATPase/metabolism , Sorbitol/metabolism , Superoxides/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Triglycerides/blood , Tyrosine/drug effects , Tyrosine/metabolism , Vasodilation/drug effects , Vasodilator Agents/pharmacology
17.
J Pediatr Surg ; 36(8): 1171-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11479850

ABSTRACT

PURPOSE: The purpose of this report is to detail the nutritional sequelae seen in survivors of congenital diaphragmatic hernia (CDH) followed in a multidisciplinary clinic. METHODS: Data on 121 surviving CDH patients seen between 1990 and 2000 were collected. Regression analysis was used to determine the impact of factors such as Apgar score, birth weight, extracorporeal membrane oxygenation (ECMO), and patch repair on outcomes associated with nutritional morbidity. RESULTS: There were 100 left and 21 right CDH defects. Mean birth weight and 5-minute Apgar score were 3.1 kg (+/-0.8) and 6.8(+/-2), respectively. Extracorporeal membrane oxygenation was required in 43 (36%) patients and patch repair in 39 (32%). A gastrostomy was required in 39 (32%) patients and a fundoplication in 23 (19%) patients. The side of the defect did not affect the frequency of these procedures. Fifty-six percent of patients were below the 25th percentile for weight during most of their first year. Regression analysis found that duration of ventilation (P <.001) and the presence of a patch repair (P =.03) were independent variables predictive of failure to thrive thereby requiring a gastrostomy tube. Patch repair also was predictive of need for subsequent fundoplication caused by gastroesophageal reflux (P <.001). Twenty-nine patients (24%) had severe oral aversion. Risk factors were prolonged ventilation (P =.001) and oxygen requirement at discharge (P =.015). Two thirds of these patients subsequently improved. CONCLUSIONS: Nutritional problems continue to be a source of morbidity for survivors of CDH, particularly in the first year of life. Not surprisingly, patients who had prolonged intubation and prosthetic material at the gastroesophageal junction fared worse. Despite aggressive nutritional management, 56% of the population remained below the twenty-fifth percentile for weight. These data show the need for careful nutritional assessment in all CDH patients, especially those at high risk for malnutrition.


Subject(s)
Hernia, Diaphragmatic/epidemiology , Hernias, Diaphragmatic, Congenital , Nutrition Disorders/epidemiology , Postoperative Complications/epidemiology , Body Height , Body Weight , Child Development/physiology , Cohort Studies , Comorbidity , Female , Growth Disorders/epidemiology , Hernia, Diaphragmatic/surgery , Humans , Infant , Infant, Newborn , Linear Models , Male , Probability , Prognosis , Registries , Risk Assessment , Survivors
18.
Diabetes ; 50(8): 1927-37, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11473057

ABSTRACT

We have shown that diabetes-induced reduction in endoneurial blood flow (EBF) and impaired endothelium-dependent vascular relaxation precede slowing of motor nerve conduction velocity (MNCV) and decreased sciatic nerve Na(+)/K(+) ATPase activity. Furthermore, vascular dysfunction was accompanied by an accumulation of superoxide in arterioles that provide circulation to the sciatic nerve. In the present study, we examined the effect that treatment of streptozotocin-induced diabetic rats with antioxidants has on vascular and neural function. Diabetic rats were treated with 0.5% alpha-lipoic acid as a diet supplement or with hydroxyethyl starch deferoxamine (HES-DFO) by weekly intravenous injections at a dose of 75 mg/kg. The treatments significantly improved diabetes-induced decrease in EBF, acetylcholine-mediated vascular relaxation in arterioles that provide circulation to the region of the sciatic nerve, and MNCV. The treatments also reduced the production of superoxide by the aorta and superoxide and peroxynitrite by arterioles that provide circulation to the region of the sciatic nerve. Treating diabetic rats with alpha-lipoic acid prevented the diabetes-induced increase in thiobarbituric acid-reactive substances in serum and significantly improved lens glutathione levels. In contrast, treating diabetic rats with HES-DFO did not prevent diabetes-induced changes of either of these markers of oxidative stress. Diabetes-induced increase in sciatic nerve conjugated diene levels was not improved by treatment with either alpha-lipoic acid or HES-DFO. Treating diabetic rats with alpha-lipoic acid but not HES-DFO partially improved sciatic nerve Na(+)/K(+) ATPase activity and myo-inositol content. The increase in sciatic nerve sorbitol levels in diabetic rats was unchanged by either treatment. These studies suggest that diabetes-induced oxidative stress and the generation of superoxide may be partially responsible for the development of diabetic vascular and neural complications.


Subject(s)
Antioxidants/pharmacology , Arterioles/physiopathology , Diabetes Mellitus, Experimental/physiopathology , Motor Neurons/physiology , Neural Conduction/drug effects , Sciatic Nerve/blood supply , Sciatic Nerve/physiopathology , Thioctic Acid/pharmacology , Animals , Aorta/drug effects , Aorta/physiopathology , Arterioles/drug effects , Dietary Supplements , Inositol/metabolism , Male , Microscopy, Video , Motor Neurons/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiopathology , Nitrates/metabolism , Rats , Rats, Sprague-Dawley , Reference Values , Regional Blood Flow/drug effects , Sciatic Nerve/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Sorbitol/metabolism , Superoxides/metabolism , Thioctic Acid/administration & dosage , Vasodilation/drug effects , Vasodilation/physiology
19.
J Pediatr ; 139(1): 27-33, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11445790

ABSTRACT

OBJECTIVE: To determine correlates of clinical outcomes in patients with short bowel syndrome (SBS). METHODS: Retrospective medical record review of neonates treated between 1986 and 1998 who met our criteria for SBS: dependence on parenteral nutrition (PN) for at least 90 days after surgical therapy for congenital or acquired intestinal diseases. RESULTS: Thirty subjects with complete data were identified; 13 (43%) had necrotizing enterocolitis, and 17 (57%)had intestinal malformations. Mean (SD) residual small bowel length was 83 (67) cm. Enteral feeding with breastmilk (r = -0.821) or an amino acid-based formula (r = -0.793) was associated with a shorter duration of PN, as were longer residual small bowel length (r = -0.475) and percentage of calories received enterally at 6 weeks after surgery(r = -0.527). Shorter time without diverting ileostomy or colostomy (r = 0.400), enteral feeding with a protein hydrolysate formula (r = -0.476), and percentage of calories received enterally at 6 weeks after surgery (r = -0.504) were associated with a lower peak direct bilirubin concentration. Presence of an intact ileocecal valve and frequency of catheter-related infections were not significantly correlated with duration of PN. In multivariate analysis, only residual small bowel length was a significant independent predictor of duration of PN, and only less time with a diverting ostomy was an independent predictor of peak direct bilirubin concentration. CONCLUSIONS: Although residual small bowel length remains an important predictor of duration of PN use in infants with SBS, other factors, such as use of breast milk or amino acid-based formula, may also play a role in intestinal adaptation. In addition, prompt restoration of intestinal continuity is associated with lowered risk of cholestatic liver disease. Early enteral feeding after surgery is associated both with reduced duration of PN and less cholestasis.


Subject(s)
Parenteral Nutrition , Short Bowel Syndrome/therapy , Adaptation, Physiological , Cholestasis/epidemiology , Enteral Nutrition , Enterocolitis, Necrotizing/therapy , Female , Food, Formulated , Humans , Infant, Newborn , Intestines/abnormalities , Intestines/physiology , Male , Milk, Human , Multivariate Analysis , Postoperative Care , Retrospective Studies , Risk Factors , Short Bowel Syndrome/epidemiology , Short Bowel Syndrome/surgery , Time Factors , Treatment Outcome
20.
Am J Physiol Regul Integr Comp Physiol ; 281(1): R246-53, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11404300

ABSTRACT

Dilatation of cerebral arterioles in response to arachidonic acid is dependent on activity of cyclooxygenase. In this study, we examined mechanisms that mediate dilatation of the basilar artery in response to arachidonate. Diameter of the basilar artery (baseline diameter = 216 +/- 7 micrometer) (means +/- SE) was measured using a cranial window in anesthetized rats. Arachidonic acid (10 and 100 microM) produced concentration-dependent vasodilatation that was not inhibited by indomethacin (10 mg/kg iv) or N(G)-nitro-L-arginine (100 microM) but was inhibited markedly by baicalein (10 micrometerM) or nordihydroguaiaretic acid (NDGA; 10 microM), inhibitors of the lipoxygenase pathway. Dilatation of the basilar artery was also inhibited markedly by tetraethylammonium ion (TEA; 1 mM) or iberiotoxin (50 nM), inhibitors of calcium-dependent potassium channels. For example, 10 microM arachidonate dilated the basilar artery by 19 +/- 7 and 1 +/- 1% in the absence and presence of iberiotoxin, respectively. Measurements of membrane potential indicated that arachidonate produced hyperpolarization of the basilar artery that was blocked completely by TEA. Incubation with [(3)H]arachidonic acid followed by reverse-phase and chiral HPLC indicated that the basilar artery produces relatively small quantities of prostanoids but large quantities of 12(S)-hydroxyeicosatetraenoic acid (12-S-HETE), a lipoxygenase product. Moreover, the production of 12-HETE was inhibited by baicalein or NDGA. These findings suggest that dilatation of the basilar artery in response to arachidonate is mediated by a product(s) of the lipoxygenase pathway, with activation of calcium-dependent potassium channels and hyperpolarization of vascular muscle.


Subject(s)
Arachidonic Acid/pharmacology , Basilar Artery/physiology , Flavanones , Lipoxygenase/metabolism , Potassium Channels/metabolism , Vasodilation/physiology , 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/metabolism , Animals , Basilar Artery/drug effects , Cyclooxygenase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Indomethacin/pharmacology , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Muscle, Smooth, Vascular/enzymology , Nitric Oxide Synthase/metabolism , Nitroarginine/pharmacology , Peptides/pharmacology , Rats , Rats, Sprague-Dawley , Tetraethylammonium/pharmacology , Tritium , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL